Study, Year | ICH PCC3 | ICH PCC4 | GIB PCC3 | GIB PCC4 | Other PCC3 | Other PCC4 | Not listed PCC3 | Not listed PCC4 |
---|---|---|---|---|---|---|---|---|
Al-Majzoub et al., 2016 [20] | 26 (74.3%) | 12 (66.7%) | 7 (20%) | 2 (11.1%) | 2 (5.1%) | 3 (16.7%) | NR | NR |
DeAngelo et al., 2018 [22] | 21 (61.8%) | 10 (76.9%) | 0 (0%) | 2 (15.4%) | 2 (5.9%) | 1 (7.7%) | Thoracic 2 (5.9%), genitourinary GU 1 (2.9%), intraabdominal and retroperitoneal 8 (23.5%) | 0 (0%) |
Fischer et al., 2018 [24] | 100% | 100% | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Holt et al., 2018 [25] | 48 (62%) | 23 (40%) | 5 (7%) | 14 (24%) | 13 (16%) | 4 (7%) | Chest Bleeds = 4 (6%) Multiple = 7 (9%) Missing = 0 | Chest Bleeds PCC4 = 0 Multiple = 15 (25%) Missing = 1 (2%) |
Jones et al., 2016 [27] | 80 (95.2%) | 40 (62.5%) | 2 (2.4%) | 11 (17.2%) | 2 (2.4%) | 13 (20.3%) | NR | NR |
Kuroski et al., 2017 [28] | 48 (70.6%) | 54 (78.3%) | 4 (5.9%) | 2 (2.9%) | 12 (17.6%) | 10 (14.5%) | Retroperitoneal: 2 (2.9%), Emergent Surgery: 2 (2.9%) | Retroperitoneal: 2 (2.9%), Emergent Surgery: 1 (1.4%) |
Mangram et al., 2016 [30]* | NR | NR | NR | NR | NR | NR | NR | NR |
Margraf et al., 2020 [31] | 31 (54.4%) | 19 (82.6%) | 10 (17.5%) | 2 (8.7%) | 16 (28.1%) | 2 (8.7%) | NR | NR |
Mohan et al., 2018 [32] | 45 (35%) (both groups) | 45 (35%) (both groups) | 33 (26%) (both groups) | 33 (26%) (both groups) | 29 (23%) (both groups) | 29 (23%) (both groups) | Periprocedural 21 (16%) (both groups) | Periprocedural 21 (16%) (both groups) |
Voils et al., 2015 [33] | 65 (60%) | 34 (61%) | 7 (6%) | 10 (18%) | 6 (6%) | 0 (0%) | IA/thoracic 12 (11%) | IA/thoracic 8 (14%) |
Cang et al., 2014 [21] | NR | NR | NR | NR | NR | NR | NR | NR |
Di Napoli et al., 2014 [23] | 51 (100%) | 18 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | NR |
Kotsianas et al., 2015 [26] | 100% | 100% | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Peck et al., 2016 [29] | 100% | 100% | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Wagner et al., 2019 [34] | 62% | 50% | NR | NR | NR | NR | NR | NR |